Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Primary medical therapy for acromegaly.

Literature DB >> 12641619

Primary medical therapy for acromegaly.

Abstract

There is now considerable evidence that the clinical outcome in patients with acromegaly can be improved very substantially by means of better surgical expertise and effective medical therapies used in a flexible and innovative manner. Medical therapy alone in patients who have not undergone surgery or radiotherapy (primary medical therapy) offers the prospect of near normalisation of GH/IGF-I levels together with substantial tumour shrinkage in a significant number of patients.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2003 PMID： 12641619 DOI： 10.1046/j.1365-2265.2003.01734.x

Source DB: PubMed Journal: Clin Endocrinol (Oxf) ISSN： 0300-0664 Impact factor: 3.478

Keyword Cloud
Cited

19 in total

Review 1. Growth hormone and its disorders.

Authors: J Ayuk; M C Sheppard
Journal: Postgrad Med J Date: 2006-01 Impact factor: 2.401

2. Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levels.

Authors: J R Lindsay; E M McConnell; S J Hunter; D R McCance; B Sheridan; A B Atkinson
Journal: Pituitary Date: 2004 Impact factor: 4.107

3. Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response.

Authors: R Helseth; S M Carlsen; J Bollerslev; J Svartberg; M Øksnes; S Skeie; S L Fougner
Journal: Endocrine Date: 2015-07-16 Impact factor: 3.633

4. Cost-effectiveness analysis of two therapeutic schemes in the treatment of acromegaly: a retrospective study of 168 cases.

Authors: L Duan; M Huang; H Yan; Y Zhang; F Gu
Journal: J Endocrinol Invest Date: 2015-03-18 Impact factor: 4.256

Review 5. Acromegaly.

Authors: Massimo Scacchi; Francesco Cavagnini
Journal: Pituitary Date: 2006 Impact factor: 4.107

Primary medical therapy for acromegaly.

Review 1. Growth hormone and its disorders.

2. Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levels.

3. Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response.

4. Cost-effectiveness analysis of two therapeutic schemes in the treatment of acromegaly: a retrospective study of 168 cases.

Review 5. Acromegaly.

Review 6. Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.

Review 7. Novel pituitary ligands: peroxisome proliferator activating receptor-gamma.

8. Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.

Review 9. Pituitary tumors in childhood: update of diagnosis, treatment and molecular genetics.

Review 10. Octreotide long-acting release (LAR): a review of its use in the management of acromegaly.